<Header>
<FileStats>
    <FileName>20161031_10-K-A_edgar_data_719135_0001009448-16-000055_1.txt</FileName>
    <GrossFileSize>48427</GrossFileSize>
    <NetFileSize>6041</NetFileSize>
    <ASCII_Embedded_Chars>0</ASCII_Embedded_Chars>
    <HTML_Chars>37666</HTML_Chars>
    <XBRL_Chars>0</XBRL_Chars>
    <XML_Chars>0</XML_Chars>
    <N_Tables>0</N_Tables>
    <N_Exhibits>2</N_Exhibits>
</FileStats>
<SEC-Header>
0001009448-16-000055.hdr.sgml : 20161031
<ACCEPTANCE-DATETIME>20161031120503
ACCESSION NUMBER:		0001009448-16-000055
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151231
FILED AS OF DATE:		20161031
DATE AS OF CHANGE:		20161031

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOVIE MEDICAL Corp
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31885
		FILM NUMBER:		161960712

	BUSINESS ADDRESS:	
		STREET 1:		4 MANHATTANVILLE ROAD, SUITE 106
		CITY:			PURCHASE
		STATE:			NY
		ZIP:			10577
		BUSINESS PHONE:		800-537-2790

	MAIL ADDRESS:	
		STREET 1:		4 MANHATTANVILLE ROAD, SUITE 106
		CITY:			PURCHASE
		STATE:			NY
		ZIP:			10577

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL CORP
		DATE OF NAME CHANGE:	19990216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AN CON GENETICS INC
		DATE OF NAME CHANGE:	19920703

</SEC-Header>
</Header>

 0001009448-16-000055.txt : 20161031

10-K/A
 1
 bovie10ka2015.htm
 BOVIE 10K/A 12/31/2015

bovie10ka2015.htm 

U.S. SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 10-K/A 

Amendment No. 1 

x  ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the fiscal year ended  December 31, 2015  

Commission file number  0-12183  

BOVIE MEDICAL CORPORATION 

(Exact name of registrant as specified in its charter) 

Delaware 

11-2644611 

(State or other jurisdiction of 

incorporation or organization) 

(IRS Employer 

Identification No.) 

4 Manhattanville Road, Suite 106, Purchase, NY 10577  

(Address of principal executive offices) 

(914) 468-4009  

(Issuer's telephone number) 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each Class 

Name of each Exchange on which registered 

Common Stock, $.001 Par Value 

NYSE MKT Market 

Securities registered under Section 12(g) of the Exchange Act: 

None 

Indicate by check mark if the Company is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes:  o  No  x  

Indicate by check mark if the Company is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes:  o  No  x  

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes:  x  No  o  

Indicate by check mark whether the registrant submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (para   232.405 of this chapter) during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files). Yes:  x  No  o  

Indicate by checkmark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  o  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act (Check one): 

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

x 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes:  o  No  x  

The aggregate market value of the voting stock held by non-affiliates computed by reference to the price at which the stock was sold, or the average bid and asked prices of such stock, as of June 30, 2015, the registrant's most recently completed second fiscal quarter, was approximately $59,780,649. 

The number of shares of the registrant's $.001 par value common stock outstanding on the NYSE MKT exchange as of March 16, 2016 was 27,051,172. 

Company Symbol-BVX 

Company SIC (Standard Industrial Code)-3841 

DOCUMENTS INCORPORATED BY REFERENCE 

None. 

EXPLANATORY NOTE 

This Amendment No. 1 on Form 10-K/A to Bovie Medical Corporation s Annual Report on Form 10-K for the fiscal year ended December 31, 2015 is being filed solely for the purpose of including the auditor s consent which was inadvertently omitted. 

SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in Clearwater, Florida on October 31, 2016. 

Bovie Medical Corporation 

By: 

/s/ Robert L. Gershon 

Robert L. Gershon 

Chief Executive Officer and Director 

(Principal Executive Officer) 

By: 

/s/ Jay D. Ewers 

Jay D. Ewers 

Chief Financial Officer, 

Treasurer, and Secretary 

(Principal Financial Officer) 

EXHIBIT INDEX 

Exhibit Number  

23.1*                      Consent of Frazier   Deeter, LLC 

23.2*                      Consent of Kingery   Crouse, PA 

*           Filed herewith 

<EX-23.1>
 2
 exhibit231.htm
 EXHIBIT 23.1 CONSENT - FRAZER & DEETER

exhibit231.htm 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

To the Board of Directors and Stockholders of 

Bovie Medical Corporation 

Purchase, New York 

We hereby consent to the incorporation by reference in Registration Statement Numbers 333-195624 and 333-207206 on Form S-8 and Registration Statement Numbers 333-200986 and 333-203422 on Form S-3 of Bovie Medical Corporation, of our report dated March 18, 2016 on the consolidated financial statements of Bovie Medical Corporation as of and for the years ended December 31, 2015 and 2014, appearing in this Annual Report on Form 10-K.. 

/s/ Frazier   Deeter, LLC 

Frazier   Deeter, LLC 

Tampa, Florida 

October 31, 2016 

</EX-23.1>

<EX-23.2>
 3
 exhibit232.htm
 EXHIBIT 23.2 CONSENT - KINGERY & CROUSE

exhibit232.htm 

CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTING FIRM 

To the Board of Directors and Stockholders of Bovie Medical Corporation 

We hereby consent to the incorporation by reference in Registration Statement Numbers 333-195624 and 333-207206 on Form S-8 and Registration Statement Numbers 333-200986 and 333-203422 on Form S-3 of Bovie Medical Corporation, of our report dated March 31, 2014, except for Note 19 as to which the date is May 8, 2014, on the consolidated statements of operations, stockholders  equity, and cash flows for the year ended December 31, 2013 of Bovie Medical Corporation, appearing in this Annual Report on Form 10-K.. 

/s/ Kingery   Crouse, PA 

Kingery   Crouse, PA 

Tampa, Florida 

October 31, 2016 

</EX-23.2>

